
Prediction of initial dosage of tacrolimus in patients with idiopathic membranous nephropathy by testing CYP3A5 genetic polymorphisms
Prediction of initial dosage of tacrolimus in patients with idiopathic membranous nephropathy by testing CYP3A5 genetic polymorphisms
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |